Second malignant neoplasms in children: an update from the Late Effects Study Group

Area of Science:

• Oncology
• Cancer Epidemiology

Background:

• Childhood cancer survivors face elevated risks for developing subsequent neoplasms.
• Understanding the patterns and risk factors for second malignant neoplasms (SMN) is crucial for long-term survivor care.

Purpose of the Study:

• To update findings on SMN in individuals treated for childhood cancer.
• To analyze the types of first and second neoplasms, therapies, and predisposing factors in a cohort of childhood cancer survivors.

Main Methods:

• Retrospective analysis of 292 cases with 308 second malignant neoplasms (SMN) in childhood cancer survivors.
• Data collection on primary cancer type, SMN type, treatment modalities (radiation, chemotherapy), and genetic predisposing conditions.

Main Results:

• Retinoblastoma, Hodgkin's disease, soft-tissue sarcomas, and Wilms' tumor were common first neoplasms associated with SMN.
• Bone sarcomas were the most frequent SMN in irradiated sites; acute leukemia was common in non-irradiated sites.
• Genetic conditions like retinoblastoma and neurofibromatosis were present in 73 cases; 17 patients developed three or four neoplasms.

Conclusions:

• While radiation, chemotherapy, and genetic factors are primary drivers of SMN in childhood cancer survivors, some cases remain unexplained.
• These findings highlight the complex etiology of second cancers and the need for ongoing surveillance in this population.